Duncan Whitney Joins US Genomics as VP of R&D, Samuel Broder Tapped as New Director of Protein Design Labs, Daniel Von Hoff Joins SAB of Spectrum Pharmaceuticals, Greg Lucier Becomes Trustee of Burnham Institute, and Others

Oct 05, 2005

Duncan Whitney has become vice president of research and development at US Genomics, the company said last week. He joins US Genomics from Exact Sciences, where he was vice president of technology.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Mysterious Third Group

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

This Week in Science

In Science this week: reduction in bee phylogenetic diversity, and more.

In the Past

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

New Bases, New Drugs

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Main menu